Ensign Peak Advisors, Inc Alkermes Plc. Transaction History
Ensign Peak Advisors, Inc
- $55.3 Billion
- Q4 2024
A detailed history of Ensign Peak Advisors, Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 62,916 shares of ALKS stock, worth $2.12 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,916
Previous 62,916
-0.0%
Holding current value
$2.12 Million
Previous $1.76 Million
2.73%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ALKS
# of Institutions
375Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$981 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$623 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$413 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$297 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$255 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.53B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...